[52] Such studies are encouraged as they would serve the dual purpose of characterizing the mechanism of cyclophilin inhibitors in blocking HBRV production and for identifying novel management strategies for patients with PBC. The gene discussed is PPIB; the disease is primary biliary cholangitis.